Hearing Test Response May ID Newborns at Risk for Autism

THURSDAY, Nov. 19, 2020 -- Newborns exhibit neurophysiological variation associated with autism spectrum disorder (ASD), according to a report published online Nov. 2 in Autism Research.

Oren Miron, from Harvard Medical School in Boston, and colleagues collected auditory brainstem response (ABR) data on 139,154 newborns from their Universal Newborn Hearing Screening, including 321 who were subsequently diagnosed with ASD.

The researchers found that compared with the non-ASD newborns, ASD newborns had significant prolongations of the ABR phase and V-negative latency. Compared with previous studies in older ASD samples, newborns in the ASD group also exhibited greater variance in their latencies; this was likely partially due to low intensity of the ABR stimulus.

"We know autism spectrum disorder is connected to how children process sound, so even if the child's hearing is normal, it can still be processed differently," a coauthor said in a statement. "With better understanding of how ABR testing can be used to identify at-risk babies, we can flag children who might be at risk."

Abstract/Full Text

© 2020 HealthDay. All rights reserved.

Posted: November 2020

Read this next

Maternal Use of Valproic Acid Linked to ASD, ADHD in Offspring

THURSDAY, Oct. 29, 2020 -- Maternal use of valproic acid, but not lamotrigine, is associated with an increased risk for autism spectrum disorder (ASD) and...

Autism, ADHD Linked to More Doctor, Hospital Visits by Age 1

MONDAY, Oct. 19, 2020 -- Children with autism spectrum disorder (ASD) and/or attention-deficit/hyperactivity disorder (ADHD) have more doctor and hospital visits during infancy,...

Maternal Epidural During Birth Linked to Later Autism in Kids

WEDNESDAY, Oct. 14, 2020 -- Exposure to maternal epidural analgesia during vaginal delivery may increase the later risk for autism spectrum disorders (ASD) for children, according...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.